Clinical trial Recruiting at 1 site Interventional Ages 5 to 12

Comparing home sleep apnea testing to in-lab testing in children

Official title: Home Sleep Apnea Testing Compared to In-lab Polysomnography for the Evaluation of Obstructive Sleep Apnea in Children

Run by Children's Hospital of Philadelphia · NCT05382754 · Data updated 2026-11-12

This study is testing whether home sleep apnea tests are just as good as in-lab tests for diagnosing sleep apnea in children.

Quick facts

Study typeInterventional
Ages5 Years to 12 Years
SexAll
Enrollment317 (estimated)
SponsorChildren's Hospital of Philadelphia
Academic / other
Locations1 site (Philadelphia, Pennsylvania)
StatusRecruiting
StartedMarch 29, 2023
Main results expectedDecember 2026
Study endsJuly 2027
Registry record updatedApril 21, 2026
Trial IDNCT05382754 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are children aged 5-12 years who have been referred for diagnostic PSG for suspected obstructive sleep apnea.

Probably not a fit

Patients who have had a PSG within the last three years or have specific medical conditions such as Down syndrome or require supplemental oxygen during sleep may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of home sleep apnea testing (HSAT) compared to the traditional in-lab polysomnography (PSG) for diagnosing obstructive sleep apnea (OSA) in children. The study will assess the accuracy of both testing methods, the impact on therapeutic decision-making, and the acceptability of HSAT from the perspectives of both parents and children. Participants will be randomly assigned to undergo either HSAT or PSG first, followed by the alternate test within a week. The trial aims to provide insights into whether HSAT can be a viable alternative to PSG in pediatric patients.

Why it matters

Potential benefit: If successful, this study could provide a more accessible and cost-effective method for diagnosing obstructive sleep apnea in children.

How similar studies have gone: While home sleep apnea testing has been accepted for adults, this study is novel as it specifically addresses its application in the pediatric population, where evidence is currently lacking.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male and female children age 5-12 years old inclusive
* Referred for diagnostic PSG at the Children's Hospital of Philadelphia (CHOP) Sleep Laboratory for evaluation of OSA as part of clinical care
* Parental/guardian permission (informed consent) and if appropriate, child assent.

Exclusion Criteria:

* Children without Down syndrome who have had a PSG within 3 years of enrollment
* Children with Down syndrome who have had a PSG within 1 year of enrollment.
* Children with a history of hypoventilation or hypoxemia or who require supplemental oxygen or positive airway pressure during sleep
* Children with a tracheostomy or tracheocutaneous fistula
* Children who live in a facility without their parent

Where it's running

  • The Children's Hospital of Philadelphia
    Philadelphia, Pennsylvania, United States
    Recruiting

Study contacts

  • Principal investigator: Christopher M Cielo, DO — Children's Hospital of Philadelphia
  • Study coordinator: Christopher M Cielo, DO
  • Email: cieloc@chop.edu
  • Phone: 2674265748

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.